Medical Equipment
Ortoma Initiates Expansion With Module for Spine Surgery
STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery. -The conclusion after a number of perfor...
2019-11-08 21:40
6485
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial
Not intended for US, Canada and UK-based media DARMSTADT, Germany, and NEW YORK, Nov. 8, 2019 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction ch...
2019-11-08 21:00
5802
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million
HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...
2019-11-07 19:04
6762
Bactiguard Holding AB (publ): Interim Report for Q3 2019
STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...
2019-11-07 15:23
6339
MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS)
SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- The 2nd China International Import Expo ( CIIE) is held in Shanghai, China, from November 5 to November 10, 2019. MEBO International, the US company of MEBO Group, attended the Expo again as a typical representative of regenerative medical technology. The ne...
2019-11-07 14:43
1045
FlexEnable Acquires Merck's OTFT Materials Portfolio for Flexible Displays
CAMBRIDGE, England, Nov. 7, 2019 /PRNewswire/ -- FlexEnable, the leader in the development and industrialisation of flexible organic electronics, has acquired Merck's portfolio of best-in-class, high-performance Organic Thin-Film Transistor (OTFT) materials, including revolutionary and highly-pat...
2019-11-07 12:00
1421
First Asia-Pacific hospital treats patients with RayStation and Radixact
SUNNYVALE, California, Nov. 7, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) –Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in theAsia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® w...
2019-11-07 09:00
2332
AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences
NEW YORK, Nov. 7, 2019 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence companies, announced a Series C fundraising round totaling$24.5 million. The financing was led by Palisades Growth Capital (PGC) with new investors from Singtel Innov8 (Inno...
2019-11-07 08:01
1871
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.
- Bioeq agreement brings promise of their leading Lucentis® biosimilar for the treatment of retinopathies one step nearer for U.S. patients - ZÜRICH, Nov. 7, 2019 /PRNewswire/ -- Bioeq IP AG ("Bioeq") today announced that it signed a license and development agreement with Coherus BioSciences, In...
2019-11-07 05:14
1991
Olympus Unveils Corporate Strategy
* Medical business to drive future growth of Olympus Corporation as a global medtech leader * A thorough transformation plan implemented to drive the change from within and ensure goals are achieved * As a result >20% operating profit margin is targeted at the fiscal year March 2023 TOKYO, ...
2019-11-06 14:08
858
Hebron Technology Co., Ltd. to Hold Annual Meeting of Shareholders on December 20, 2019
WENZHOU, China, Nov. 5, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced that ...
2019-11-06 05:05
7954
Farrer Park Hospital Introduces High Intensity Focused Ultrasound (HIFU) Treatment for Uterine Fibroid in Singapore
SINGAPORE, Nov. 5, 2019 /PRNewswire/ -- Farrer Park Hosiptal (FPH) introduces High Intensity Focused Ultrasound (HIFU) inSingapore. HIFU is a new technology for the treatment of uterine fibroids, adenomyoma, adenomyosis. It is a non-invasive surgery that uses focused ultrasound to generate hig...
2019-11-05 09:00
3407
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®
- Alliance to focus combined expertise and investment to maximise Jardiance® for people with type 2 diabetes, heart failure, and chronic kidney disease - Alliance to continue to include three product families – empagliflozin, linagliptin and insulin glargine INGELHEIM, Germany, and INDIANAPOLIS,...
2019-11-04 22:00
3842
Ossur and Alfred Mann Foundation Sign New Agreement to Extend Exploration of Mind-Controlled Prosthetics
REYKJAVIK, Iceland and SANTA CLARITA, CA, Nov. 4, 2019 /PRNewswire/ -- Jon Sigurdsson, President & CEO of Ossur and John Petrovich, CEO of the Alfred Mann Foundation (AMF) recently signed a milestone agreement that allows Ossur to further develop and license AMF's implanted myoelectric sensor (IM...
2019-11-04 15:37
3177
Picosun Expands Selection of Biocompatible ALD Materials for Medical Applications
ESPOO, Finland, Nov. 4, 2019 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions for global industries, expands its selection of biocompatible ALD materials to be used in medical applications. Picosun's TiO2 and Al2O3 processes ...
2019-11-04 13:00
889
Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease
* Oligomannate, A New Oral Treatment For Mild To Moderate Alzheimer's Disease * The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- Shanghai Green Valley Pharmaceuticals (Green Valley) today announced thatChina's National Medical Products Administrat...
2019-11-04 10:30
2263
ClinicAll Enters Cooperation Partnership With The Private Office of Sheikh Saeed Bin Ahmed Al Maktoum and SEED Group
NEW YORK, Nov. 3, 2019 /PRNewswire/ -- ClinicAll International Corporation is
excited to announce the strategic partnership withThe Private Office of Sheikh
Saeed Bin Ahmed Al Maktoum and SEED Group.
2019-11-03 19:30
1878
Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner
VISTA, California, Oct. 31, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack load...
2019-10-31 06:00
1825
Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution
PALO ALTO, California, Oct. 31, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach intoNew Zealand andAsia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order inc...
2019-10-31 04:05
6413
EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay
SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA™ (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) withFLT3 mutations (FL...
2019-10-30 18:00
1657
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9195
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7769
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
4889
